INTERLEUKIN-2 THERAPY - AN OVERVIEW

= 0.06) in contrast With all the IL-two team. These studies illustrated the addition of cytokines could enrich the result of vaccine therapy in sufferers with melanoma and highlighted the likely of applying rational mixtures of immune agents in treating sufferers with metastatic most cancers.Tregs: T regulatory cells; TME: tumor microenvironment; d